Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon Alfa-2b and Ribavirin in Decompensated HCV Cirrhosis
NCT00301509Phase 3Completed
- Sponsor
- Casa Sollievo della Sofferenza
- Start
- Jan 2002
- Modality
- Polymer-based Nanoparticles, Orthosteric Ligands, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2b, ribavirin in hepatitis C (HCV), Liver cirrhosis (LC), sponsored by Casa Sollievo della Sofferenza. Started Jan 2002; status: completed.
02
Drugs
peginterferon alfa-2bribavirin
03
Conditions
hepatitis C (HCV)Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT00301509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00301509.